Back to LYEL
MORGAN STANLEY LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
29
Latest value
$98
Q3 2026
Peak value
$711K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $143K |
| Q3 2025 | $98K |
| Q3 2025 | $16K |
| Q3 2025 | $162 |
| Q3 2025 | $345K |
| Q4 2025 | $460K |
| Q4 2025 | $118K |
| Q4 2025 | $30K |
| Q4 2025 | $61K |
| Q4 2025 | $308 |
| Q4 2025 | $653K |
| Q1 2026 | $563K |
| Q1 2026 | $77K |
| Q1 2026 | $21K |
| Q1 2026 | $39K |
| Q1 2026 | $201 |
| Q1 2026 | $426K |
| Q2 2026 | $239K |
| Q2 2026 | $38K |
| Q2 2026 | $211K |
| Q2 2026 | $27K |
| Q2 2026 | $141 |
| Q2 2026 | $4K |
| Q3 2026 | $711K |
| Q3 2026 | $58K |
| Q3 2026 | $39 |
| Q3 2026 | $88K |
| Q3 2026 | $19K |
| Q3 2026 | $98 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $98 | 10 | — | — |
| Q3 2026 | $19K | 2.0K | — | — |
| Q3 2026 | $88K | 9.0K | — | — |
| Q3 2026 | $39 | 4 | — | — |
| Q3 2026 | $58K | 5.9K | — | — |
| Q3 2026 | $711K | 72.6K | — | — |
| Q2 2026 | $4K | 311 | — | — |
| Q2 2026 | $141 | 10 | — | — |
| Q2 2026 | $27K | 2.0K | — | — |
| Q2 2026 | $211K | 15.0K | — | — |
| Q2 2026 | $38K | 2.7K | — | — |
| Q2 2026 | $239K | 17.0K | — | — |
| Q1 2026 | $426K | 21.2K | — | — |
| Q1 2026 | $201 | 10 | — | — |
| Q1 2026 | $39K | 2.0K | — | — |
| Q1 2026 | $21K | 1.0K | — | — |
| Q1 2026 | $77K | 3.8K | — | — |
| Q1 2026 | $563K | 28.1K | — | — |
| Q4 2025 | $653K | 21.2K | — | — |
| Q4 2025 | $308 | 10 | — | — |
| Q4 2025 | $61K | 2.0K | — | — |
| Q4 2025 | $30K | 986 | — | — |
| Q4 2025 | $118K | 3.8K | — | — |
| Q4 2025 | $460K | 14.9K | — | — |
| Q3 2025 | $345K | 21.2K | — | — |
| Q3 2025 | $162 | 10 | — | — |
| Q3 2025 | $16K | 986 | — | — |
| Q3 2025 | $98K | 6.0K | — | — |
| Q3 2025 | $143K | 8.8K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M